Aducanumab Update
While various opinions are circulating, and the benefits of this drug are unclear, ANA will continue to monitor the situation and provide updates as information becomes available.
bck
A New Treatment for Migraine
Thanks to the latest research, we can now target specific migraine pathways.
Dr. Klein featured in Neurology Today
Early on in their careers, two neurologists became involved in advocacy issues on behalf of neurology on a national, regional, and local level.
Four ANA physicians recognized as top doctors
Dr. Harris, Dr. Burke, and Dr. Cook received the Philadelphia Top Doctor award. Dr. Kulandaivel has been named a Top Doctor Under 40.
Dr. Klein discusses biosimilars and biologics in the Philadelphia Business Journal
Dr. Klein argues that physicians should be made aware if pharmacies switch a physician-prescribed product for a biosimilar.
Dr. Klein testifies in state congress on behalf of physicians and patients
This bill ensures that patients and physicians are made aware if the pharmacist substitutes a biosimilar product.
Dr. Klein co-authors panel publication in Headache
Fifteen members of the American Headache Society reviewed the existing literature and developed a standard procedure for nerve blocks.